Nueva Publicación: Nrf2, A Novel Therapeutic Target in Fragile X Syndrome is Modulated by NNZ2566.

Nueva Publicación: Nrf2, A Novel Therapeutic Target in Fragile X Syndrome is Modulated by NNZ2566.

Autores: Deacon R, Hurley M, Martínez Rebolledo C, Snape M, Altimiras F, Pino M, Leandro F, Glass L, Cogram P.

Genes, Brain and Behavior

Para acceder al link: Click Aquí

Donar ahora